Salomon Azoulay
Chief Medical OfficerDr. Salomon Azoulay, M.D., also known as Sam, is Chief Medical Officer of MBX Biosciences, Inc. since June 2024. He served as the Chief Medical Officer and Head of Research & Development at Sumitovant Biopharma Ltd. In this role he oversaw numerous functions including clinical development, CMC, Regulatory and medical affairs functions. Dr. Azoulay has served as Chief Medical Officer of Roivant Sciences since May 2018. He joined Roivant from Pfizer, where he served as Senior Vice President and Chief Medical Officer for Pfizer Essential Health. In that role he oversaw clinical development and medical affairs for a portfolio that included over 600 branded products as well as biosimilars and sterile injectables. He has experience in the biopharmaceutical industry and held senior leadership roles at Pfizer since 2001, including Head of Development in Japan and Senior Vice President for Medical and Development in Emerging Markets. Dr. Azoulay earned his M.D., with a specialty in cardiology, from the University of Paris VI. He also holds a D.E.S.S. in Business Administration and Management from the Sorbonne.
Positions
- Company NameMBX Biosciences, Inc.Stock CodeMBXPositionChief Medical OfficerColleagues
- SLSteven L. HoerterExecutive Chairperson, CEO & President
- JWJohn W. SmitherChief Financial Officer
- PDPete De SpainSenior Vice President of Investor Relations & Corporate Communications
- JHJeffrey HeldChief Legal Officer
- PJPatrick James HeronIndependent Director
- OHOra Hirsch PescovitzIndependent Director
- LDLaurie D. StelzerIndependent Director
- ETEdward T. MathersIndependent Director
